Literature DB >> 14715537

Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.

Helen Joseph1, Paul Balmer, Mike Bybel, Thomas Papa, Robert Ryall, Ray Borrow.   

Abstract

Meningococcal serogroup-specific immunoglobulin G (IgG), IgG1, and IgG2 concentrations were assigned to three reference sera, CDC 1992, 89-SF, and 96/562, for meningococcal serogroups A, C, Y, and W135 via the method of cross standardization. The sum of the serogroup-specific IgG1 and IgG2 concentrations determined for the four meningococcal serogroups showed good agreement with the serogroup-specific IgG either determined here or as previously represented. Following the assignment of meningococcal serogroup-specific IgG1 and IgG2 concentration to these reference sera, a meningococcal serogroup-specific IgG1 and IgG2 enzyme-linked immunosorbent assay protocol was developed. The serogroup A and C specific subclass distribution of a panel of adult sera collected following vaccination with any combination of meningococcal serogroup C conjugate, bivalent, or tetravalent polysaccharide vaccines was determined. For the determination of serogroup W135 and Y specific subclass distribution, an adolescent panel 28 days following a single dose of either tetravalent polysaccharide or conjugate vaccine was used. The sum of the serogroup-specific IgG1 and IgG2 showed strong correlation with the serogroup-specific total IgG determined. The assignment here of IgG1 and IgG2 subclasses to these reference sera will allow more detailed evaluation of meningococcal conjugate and polysaccharide vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715537      PMCID: PMC321340          DOI: 10.1128/cdli.11.1.1-5.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide.

Authors:  W A Hutchins; G M Carlone; M A Westerink
Journal:  J Infect Dis       Date:  1999-06       Impact factor: 5.226

2.  Immunoassay of human Neisseria meningitidis serogroup A antibody.

Authors:  K R Diakun; D C Martin; T Mininni; J Skuse; N Ziembiec; S Quataert
Journal:  Immunol Invest       Date:  1997 Aug-Dec       Impact factor: 3.657

3.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Authors:  S A Quataert; C S Kirch; L J Wiedl; D C Phipps; S Strohmeyer; C O Cimino; J Skuse; D V Madore
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

4.  Determination of parallelism and nonparallelism in bioassay dilution curves.

Authors:  B D Plikaytis; P F Holder; L B Pais; S E Maslanka; L L Gheesling; G M Carlone
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.

Authors:  D V Madore; C L Johnson; D C Phipps; M G Myers; R Eby; D H Smith
Journal:  Pediatrics       Date:  1990-10       Impact factor: 7.124

6.  Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology.

Authors:  D J Herrmann; R G Hamilton; T Barington; C E Frasch; G Arakere; O Mäkelä; L A Mitchell; J Nagel; G T Rijkers; B Zegers
Journal:  J Immunol Methods       Date:  1992-04-08       Impact factor: 2.303

7.  Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization.

Authors:  N Concepcion; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

8.  Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.

Authors:  P K Holder; S E Maslanka; L B Pais; J Dykes; B D Plikaytis; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay.

Authors:  G M Carlone; C E Frasch; G R Siber; S Quataert; L L Gheesling; S H Turner; B D Plikaytis; L O Helsel; W E DeWitt; W F Bibb
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  T cells and natural killer cells regulate human IgG subclass concentrations in SCID mice.

Authors:  D M Ambrosino; M Wang; A Ciamarra; M Chan; D L Bolon; J Minn; D A Jacobsohn; R W Finberg
Journal:  Cell Immunol       Date:  1994-04-15       Impact factor: 4.868

View more
  11 in total

1.  Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients.

Authors:  A Meerveld-Eggink; O de Weerdt; R M de Voer; G A M Berbers; H van Velzen-Blad; B J Vlaminckx; D H Biesma; G T Rijkers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-24       Impact factor: 3.267

2.  Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide.

Authors:  Peter C Giardina; Emma Longworth; Renee E Evans-Johnson; Michaelene L Bessette; Hong Zhang; Ray Borrow; Dace Madore; Philip Fernsten
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

3.  Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.

Authors:  Helen Findlow; Jo Southern; Lesley Mabey; Paul Balmer; Robert S Heyderman; Cressida Auckland; Rhonwen Morris; Elizabeth Miller; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

Authors:  Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

5.  Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.

Authors:  Richarda M de Voer; Fiona R M van der Klis; Carla W A M Engels; Ger T Rijkers; Elisabeth A Sanders; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

6.  Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan.

Authors:  Zhiming Huo; Ruchi Sinha; Edel A McNeela; Ray Borrow; Rafaela Giemza; Catherine Cosgrove; Paul T Heath; Kingston H G Mills; Rino Rappuoli; George E Griffin; David J M Lewis
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

Authors:  Y Al-Mazrou; M Khalil; R Borrow; P Balmer; J Bramwell; G Lal; N Andrews; M Al-Jeffri
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Authors:  H Findlow; M D Tapia; S O Sow; F C Haidara; F Coulibaly; A M Keita; F Diallo; M Doumbia; A Traore; N Schluterman; D A Clark; R Borrow; M M Levine
Journal:  Vaccine       Date:  2019-04-02       Impact factor: 3.641

9.  Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.

Authors:  Philippe J Guerin; Lisbeth M Naess; Carole Fogg; Einar Rosenqvist; Loretxu Pinoges; Francis Bajunirwe; Carolyn Nabasumba; Ray Borrow; Leif O Frøholm; Salah Ghabri; Vincent Batwala; Rogers Twesigye; Ingeborg S Aaberge; John-Arne Røttingen; Patrice Piola; Dominique A Caugant
Journal:  PLoS Negl Trop Dis       Date:  2008-12-02

10.  Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Authors:  Daniel Holme; Helen Findlow; Samba O Sow; Olubukola T Idoko; Marie-Pierre Preziosi; George Carlone; Brian D Plikaytis; Ray Borrow
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.